Total Funding
23
70
Total FundingPre-Seed raised
Growth Score 23 in past quarter
-35 pts
Heat Score 70 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
57273
TorMagnus Pharmaceuticals is a drug discovery firm dedicated to discovering treatments for Peroxisomal disorders.
- Talia Krainc: Founder and Chief Executive Officer
- John Fraser: Co-Founder and Chief Technical Officer
About the Company
TorMagnus Pharmaceuticals combines graph theory and network medicine approaches to use AI to aid in the identification of novel drug treatments. The immediate focus is on identifying targets for Parkinson's disease.
Women Founded
